NO990305D0 - Steroider som neurokjemiske stimulatorer av VNO for Õ lindre symptomer av PMS og angst - Google Patents

Steroider som neurokjemiske stimulatorer av VNO for Õ lindre symptomer av PMS og angst

Info

Publication number
NO990305D0
NO990305D0 NO990305A NO990305A NO990305D0 NO 990305 D0 NO990305 D0 NO 990305D0 NO 990305 A NO990305 A NO 990305A NO 990305 A NO990305 A NO 990305A NO 990305 D0 NO990305 D0 NO 990305D0
Authority
NO
Norway
Prior art keywords
pms
steroids
anxiety
vno
relieve symptoms
Prior art date
Application number
NO990305A
Other languages
English (en)
Other versions
NO990305L (no
Inventor
Clive L Jennings-White
David L Berliner
Nathan W Adams
Luis Bloch-Monti
Original Assignee
Pherin Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/686,092 external-priority patent/US6057439A/en
Application filed by Pherin Pharm Inc filed Critical Pherin Pharm Inc
Publication of NO990305D0 publication Critical patent/NO990305D0/no
Publication of NO990305L publication Critical patent/NO990305L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/002—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 13 (17)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/005—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/007—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO990305A 1996-07-23 1999-01-22 Steroider som neurokjemiske stimulatorer av VNO for Õ lindre symptomer av PMS og angst NO990305L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/686,092 US6057439A (en) 1994-08-04 1996-07-23 Steroids as neurochemical stimulators of the VNO to alleviate symptoms of PMS and anxiety
US72586296A 1996-10-04 1996-10-04
PCT/US1997/013035 WO1998003207A1 (en) 1996-07-23 1997-07-23 Steroids as neurochemical stimulators of the vno to alleviate symptoms of pms and anxiety

Publications (2)

Publication Number Publication Date
NO990305D0 true NO990305D0 (no) 1999-01-22
NO990305L NO990305L (no) 1999-03-22

Family

ID=27103741

Family Applications (1)

Application Number Title Priority Date Filing Date
NO990305A NO990305L (no) 1996-07-23 1999-01-22 Steroider som neurokjemiske stimulatorer av VNO for Õ lindre symptomer av PMS og angst

Country Status (15)

Country Link
EP (1) EP0914165B1 (no)
JP (1) JP4450435B2 (no)
KR (1) KR20000067970A (no)
CN (1) CN1226837A (no)
AT (1) ATE342721T1 (no)
AU (1) AU726625B2 (no)
BG (1) BG103115A (no)
BR (1) BR9711812A (no)
CA (1) CA2260253A1 (no)
DE (1) DE69736833T2 (no)
ES (1) ES2273374T3 (no)
NO (1) NO990305L (no)
NZ (1) NZ333671A (no)
PL (1) PL331357A1 (no)
WO (1) WO1998003207A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922699A (en) * 1996-06-07 1999-07-13 Pherin Corporation 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function
FR2791572A1 (fr) * 1999-03-31 2000-10-06 Adir Utilisation d'hormones sexuelles pour l'obtention d'une composition pharmaceutique nasale utile pour le traitement des saignements uterins indesirables
AU1261501A (en) * 1999-12-06 2001-06-18 Stanley L. Gore Compositions and methods for intranasal delivery of active agents to the brain
US6555531B1 (en) * 1999-12-30 2003-04-29 Pherin Pharmaceuticals, Inc. Weight promoting composition, method, and product
US8309539B2 (en) * 2005-09-09 2012-11-13 Pherin Pharmaceuticals, Inc. Acute treatment of social phobia
BRPI0910637A2 (pt) * 2008-04-09 2015-07-28 Pherin Pharm Inc Método para o tratamento de um indivíduo castrado do sexo masculino que padece de fogalhos
KR102209475B1 (ko) * 2012-12-28 2021-01-28 페린 파마슈티칼즈, 인코포레이티드 우울 장애를 치료하기 위한 프레그느-4-엔-20-인-3-온의 용도
US11419881B2 (en) * 2019-04-15 2022-08-23 Pherin Pharmaceuticals, Inc. Treatment of migraine
US20220396597A1 (en) * 2019-10-25 2022-12-15 Washington University Nmdar inhibiting agents and gabaar potentiating agents and uses thereof
CN112608358A (zh) * 2020-12-29 2021-04-06 北京大学 一种促进花粉萌发的化合物及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208227A (en) * 1987-08-25 1993-05-04 University Of Southern California Method, compositions, and compounds for modulating brain excitability
US5969168A (en) * 1991-01-07 1999-10-19 Pherin Corporation Androstanes for inducing hypothalamic effects
CA2165325A1 (en) * 1993-06-15 1994-12-22 David L. Berliner Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
PL177474B1 (pl) * 1993-06-15 1999-11-30 Pherin Pharmaceuticals Kompozycja farmaceutyczna do donosowego podawania ludziom zawierająca związek steroidowy oraz związek steroidowy
US5792757A (en) * 1994-08-04 1998-08-11 Pherin Pharmaceuticals 19-nor-pregnane steroids as neurochemical initiators of change in human hypothalamic function
US5563131A (en) * 1994-08-04 1996-10-08 Pherin Corporation Pregnane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
KR970706297A (ko) * 1994-09-29 1997-11-03 케빈 맥카티 시상하부의 효능을 유도하기 위한 신규 에스트렌류(novel estrenes for inducing hypothalamic effects)
US5922699A (en) * 1996-06-07 1999-07-13 Pherin Corporation 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function

Also Published As

Publication number Publication date
BR9711812A (pt) 1999-08-24
ES2273374T3 (es) 2007-05-01
AU3963797A (en) 1998-02-10
AU726625B2 (en) 2000-11-16
KR20000067970A (ko) 2000-11-25
PL331357A1 (en) 1999-07-05
JP2000513000A (ja) 2000-10-03
CN1226837A (zh) 1999-08-25
DE69736833D1 (de) 2006-11-30
NZ333671A (en) 2000-07-28
EP0914165B1 (en) 2006-10-18
DE69736833T2 (de) 2007-05-24
JP4450435B2 (ja) 2010-04-14
NO990305L (no) 1999-03-22
ATE342721T1 (de) 2006-11-15
BG103115A (en) 1999-09-30
CA2260253A1 (en) 1998-01-29
EP0914165A1 (en) 1999-05-12
EP0914165A4 (en) 2004-01-21
WO1998003207A1 (en) 1998-01-29

Similar Documents

Publication Publication Date Title
NZ312303A (en) Novel nor-pregnanes for inducing hypothalamic effects
NO985975L (no) Blandinger og fremgangsmÕter for frembringelse av farmakologisk aktive preparater og anvendelser derav
IL139681A0 (en) Pharmaceutical compositions containing vitamin b6
NO990305L (no) Steroider som neurokjemiske stimulatorer av VNO for Õ lindre symptomer av PMS og angst
BR9709838A (pt) Regime de administração que fornece um perfil de plasma no sangue de um inibidor de h+,k+-atpase composição farmacêutica oral uso da mesma e de inibidor h+,k+-atpase e processos para melhorar a inibição de secreção de ácido gástrico e o efeito terapêutico no tratamento de perturbações gastrintestinais e para receber um perfil estendido de plasma de um inibidor de h+,k+-atpase
NO955085D0 (no) Androstansteroider som nevrokjemiske initiatorer for forandring i menneskets hypotalamiske funksjon og beslektede farmasöytiske blandinger og metoder
TR200000149T2 (tr) Serebral nörovasküler bozuklukların, müsküler baş ağrılarının önlenmesine yönelik kompozisyonlar
SE9603725D0 (sv) New teatment
CA2258177A1 (en) 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function
NO955084D0 (no) Estrensteroider som nevrokjemiske initiatorer for forandring i menneskets hypotalamiske funksjon og beslektede farmasöytiske blandinger og metoder
MX9702253A (es) Nuevos estrenos para inducir efectos hipotalamicos
MX9700881A (es) Pregnanos y colanos como indicadores neuroquimicos del cambio en la funcion hipotalamica.
MXPA94000705A (es) Esteroides de estreno como iniciadores neuroquimicos del cambio en la funcion hipotalamica humana ycomposiciones farmaceuticas y metodos relacionados.
CA2248841A1 (en) Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy
BR9816142A (pt) Esteróides de 19-nor-colano como iniciadores neuroquìmicos de mudança na função hipotalâmica humana
TW289730B (en) Pharmaceutical composition for alleviating the symptoms of psychoses, depression or anxiety comprising androstene steroids

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application